In summary, the effect exerted on neurodegeneration by vitamin B12 deficiency and hyperhomocysteinemia is not only due to PP2A inactivation and tau hyperphosphorylation but also direct binding of vitamin B12 to tau protein, inhibiting its fibrillation and aggregation [62]. The gene discussed is MAPT; the disease is vitamin B12 deficiency.